
COVID-19 Vaccine FAQs and Guidance for Mass General Cancer Center Patients
View frequently asked questions and guidance about the COVID-19 vaccine for Cancer Center patients.
Read moreSafe Care CommitmentGet the latest news on COVID-19, the vaccine and care at Mass General.Learn more
View frequently asked questions and guidance about the COVID-19 vaccine for Cancer Center patients.
Read moreLearn how Marcela Maus, MD, PhD, director of the cellular immunotherapy program at Mass General Cancer Center, became a leader in the field of cell therapy.
View stories from our community of patients, friends, family, clinicians, and staff.
Advances in Motion provides health care professionals with information about the latest breakthroughs, research and clinical advances from Massachusetts General Hospital.
Explore our library of continuing medical education and view upcoming events.
View the latest research highlights and featured publications from the Center for Cancer Research.
Genetic testing for cancer risk assessment was first offered in 1996 for a limited number of genes. Cancer genetics has changed significantly since then. Stephanie Hicks, MS, CGC, discusses the role of genetic testing in the cancer setting and how it has evolved over time.
Held virtually on June 23rd, our 2022 Mass General Cancer Center Survivorship Conference featured speakers Ryan Sullivan, MD and Giselle Perez, PhD, and moderator Jeffery Peppercorn, MD, MPH.
Ever wonder when or how to start talking with your kids about a hereditary cancer in the family? Carly Grant, MS, CGC, covers the latest research on discussing hereditary cancer with children of all ages.
Ovarian cancer is rare, but did you know that it can run in families? Janette Lawrence, MS, CGC, gives an overview of hereditary ovarian cancer and what you can do if it's detected in your family.
There are many different types of genetic testing for cancer. Kristen Shannon, MS, CGC, discusses the differences between these types of tests and how to choose the right one.
Noopur Raje, MD, Marcela Maus, MD, PhD and Matthew Frigault, MD discuss the power and evolution of immune therapies, specifically, CAR T-Cell therapy in treating cancer.
In this video, learn how the Center for Innovation in Early Cancer Detection is focused on increasing the development of new cancer-detecting technologies, and hear about their important Fire Health Study, a partnership with the Boston Fire Department to help screen firefighters for cancer.
Dr. Paula Rauch discusses parenting challenges from diagnosis through treatment and offers guidance to support the emotional health and well-being of children when a parent has cancer.
The team from the Collaborative Care and Community Engagement Program at Mass General Cancer Center share how they strive to improve cancer treatment for patients with mental illness.
Lymphedema is swelling caused by fluid that collects in tissue under the skin. Clinical research coordinators discuss the Lymphedema Screening Program at Mass General and their current LymphVAX project related to COVID-19 vaccination.
Learn about the most recent updates on the treatment and management of individuals at risk for kidney cancer, and the role of genetic counseling.
Billy Costa talks with Dr. Matt Frigault and oncology social worker Lauren DeMarco to learn more about the latest in CAR T-cell therapies and what it all means for patients.
Billy Costa talks with Dr. Salvia Jain to learn more about the treatments and therapies available for patients with T-cell lymphoma.
Billy Costa talks with Dr. Robb Friedman, Dr. Amy Comander, and Dr. Larry Blaszkowsky about how the care teams at Mass General Cancer Center's community locations provide patients with access to world-class cancer care close to home.
In this presentation from February 3, 2022, Dr. Daniel Chung discusses specific risks for colon cancer that can help guide your choice of screening test.
Learn about screening, prevention, medical management and treatment options for those with gene mutations or those at hereditary risk for pancreatic cancer.
A mammogram is an x-ray picture of the breast that help detect breast cancer. In this presentation, Randy Miles, MD, MPH, examines the risks and benefits of routine breast cancer screening starting at age 40 at the individual level. He also discusses the role of advanced imaging techniques.
Learn about clinical trials in this video with Elizabeth Abraham, RN, clinical research nurse at Mass General Cancer Center.
An integral part of one of the world’s most distinguished academic medical centers, the Massachusetts General Hospital Cancer Center is among the leading cancer care providers in the United States.